Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance
Abstract
Genomic profiling of ER + /HER2 − breast tumors after short-term estrogen deprivation revealed alterations associated with intrinsic resistance and provided mechanistic insights.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 09, 2017
- Source ID
- 10.1126/scitranslmed.aai7993
Entities
People
- Carlos L Arteaga
- Christian D. Young
- Danielle Murphy
- Eliezer Van Allen
- Erica L Mayer
- Henry Gόmez
- Ingrid A. Mayer
- Ingrid Meszoely
- Jason Christiansen
- Jeffrey S Ross
- Jennifer M Giltnane
- Justin M. Balko
- Kai Wang
- Katherine E. Hutchinson
- Kerry Fitzgerald
- Levi Garraway
- Liping Du
- Luigi Formisano
- Maria G Kuba
- Melinda E. Sanders
- Mellissa J. Nixon
- Monica Rizzo
- Mónica Valeria Estrada
- Nikhil Wagle
- Paula González Ericsson
- Phillip J. Stephens
- Roman Yelensky
- Sarat Chandarlapaty
- Thomas P. Stricker
- Vandana G Abramson
- Vincent A. Miller
- Violeta Sanchez
- Weiyi Toy
- Xinmeng J Mu
- Yu Shyr
Organizations
- Albany Medical College
- Broad Institute
- Dana–Farber Cancer Institute
- Emory University
- Foundation Medicine
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute
- National Institutes of Health
- Novartis
- Susan G. Komen for the Cure
- The Breast Cancer Research Foundation
- United States Department of Defense
- Vanderbilt University
- Vanderbilt University Medical Center
- Vanderbilt-Ingram Cancer Center